Stay updated on Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.

Latest updates to the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange Detected- Added a government funding operating-status notice and updated operating details for NIH Clinical Center (high importance). - Updated version from v3.1.0 to v3.2.0 (moderate importance).SummaryDifference4%
- Check24 days agoChange DetectedUpdated to Revision: v3.1.0 and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while keeping the revision label as the primary addition.SummaryDifference0.4%
- Check39 days agoChange DetectedChanged the place name from Mexico to México and updated the revision to v3.0.2, with the Back to Top link removed; no substantive changes to core content (pricing, stock, times).SummaryDifference1%
- Check46 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%
- Check53 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations across various countries in South America and Mexico, while removing outdated location entries and some related medical topics.SummaryDifference16%
- Check67 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.